The synthesis plan commenced with preparation of the
Witkop cyclization precursor 6 from the known 7-diphe-
nylmethyl ether of indole, 3, itself available via Bartoli
indole synthesis in two steps,6 Scheme 1. Installation of the
tryptophan side chain proceeded via initial formylation of
3 at C(3) and then EmmonsꢀHorner alkene extension
with the anion of methyl (2,2-dichloropropionylamino)-
(dimethylphosphoryl)acetate to furnish the (Z)-dehydro-
tryptophan derivative 5. Exposure of 5 to catalytic
Wilkinson’s catalyst and high pressure hydrogen gas
served to both saturate the side chain and cleave the
diphenylmethyl ether function at C(700) to deliver the
Witkop substrate 6 following deprotection of the indole
nitrogen.
yielding Witkop cyclizations reported to date.8 The
Witkop cyclization has been subject to numerous
mechanistic studies7 and has been utilized as a pivotal
step in many total syntheses of cognate indole alkaloids.8
Application of the consensus Witkop mechanistic
paradigm to the chemistry of 6 is detailed below. This
speculation features two consecutive photochemically
mediated electron transfers that labilize both CꢀCl
bonds for further chemistry. In the first sequence, chloride
loss promotes diradical 8 generation, and regioselective
closure within 8 then constitutes the key CꢀC bond
forming step of this Witkop cyclization. A subsequent
photoelectron transfer within 9 provides a low-energy
pathway for Clꢀ, and then Hþ, loss to deliver the enone
product 13, although it is not unreasonable to imagine that
HCl loss may proceed from 9 without intervention of
excited state chemistry.
Scheme 1. Synthesis of the Witkop Cyclization Precursor
Scheme 2. Witkop Cyclization of 6, with Mechanistic Speculation
The key Witkop cyclization proceeded smoothly
upon irradiation of dilute solutions of 6 in acetonitrile
in a quartz vessel with 254 nm light, Scheme 2. The
isolated product, 13, represents one of the highest
(5) Yonemitsu, O.; Cerutti, P.; Witkop, B. J. Am. Chem. Soc. 1966,
88, 3941–3945.
(6) Dobson, D.; Todd, A.; Gilmore, J. Synth. Commun. 1991, 21,
611–617.
(7) (a) McCall, M. T.; Hammond, G. S.; Yonemitsu, O.; Witkop, B.
J. Am. Chem. Soc. 1970, 92, 6991–6993. (b) Naruto, S.; Yonemitsu, O.
Tetrahedron Lett. 1975, 16, 3399–3402. (c) Hamada, T.; Ohmori, M.;
Yonemitsu, O. Tetrahedron Lett. 1977, 18, 1519–1522. (d) Naruto, S.;
Yonemitsu, O. Chem. Pharm. Bull. 1980, 28, 900–909.
Conversion of the eight-membered bridging lactam
into a cycloheptanoid structure constituted the next
synthesis objective, Scheme 3. This formal one-atom
ring contraction could be effected by initial conjugate
addition of hydride to the enone unit, which promoted
a Dieckmann cyclization of the first-formed enolate 14.
The strained tetracyclic product 15 was readily hydro-
lyzed to deliver the desired cycloheptane-bridged in-
dole substructure of dragmacidin E, 16. Tricycle 16 was
formed as an inconsequential mixture of stereoisomers
at C(6000); both diastereomers later converged to the
same product.
(8) (a) Kobayashi, T.; Spande, T. F.; Aoyagi, H.; Witkop, B. J. Org.
Chem. 1969, 12, 636–638. (b) Anderson, N. G.; Lawton, R. G. Tetra-
hedron Lett. 1977, 1843–1846. (c) Bosch, J.; Amat, M.; Sanfeliu, E.;
Miranda, M. A. Tetrahedron 1985, 41, 2557–2566. (d) Klohr, S. E.;
Cassady, J. M. Synth. Commun. 1988, 18, 671–674. (e) Beck, A. L.;
Mascal, M.; Moody, C. J.; Slawin, A. M. Z.; Williams, D. J.; Coates,
W. J. J. Chem. Soc., Perkin Trans. 1 1992, 797–811. (f) Beck, A. L.;
Mascal, M.; Moody, C. J.; Coates, W. J. J. Chem. Soc., Perkin Trans. 1
1992, 813–822. (g) Mascal, M.; Moody, C. J.; Slawin, A. M. Z.; Williams,
D. J. J. Chem. Soc., Perkin Trans. 1 1992, 823–830. (h) Nagata, R.; Endo,
Y.; Shudo, K. Chem. Pharm. Bull. 1993, 41, 369–372. (i) Mascal, M.;
Moody, C. J.; Morrell, A. I.; Slawin, A. M. Z.; Williams, D. J. J. Am.
Chem. Soc. 1993, 115, 813–814. (j) Mascal, M.; Wood, I. G.; Begley,
M. J.; Batsanov, A. S.; Walsgrove, T.; Slawin, A. M. Z.; Williams, D. J.;
Drake, A. F.; Siligardi, G. J. Chem. Soc., Perkin Trans. 1 1996, 2427–
2433. (k) Bennasar, M.-L.; Zulaica, E.; Ramirez, A.; Bosch, J. Hetero-
cycles 1996, 43, 1959–1966. (l) Ruchkina, E. L.; Blake, A. J.; Mascal, M.
Tetrahedron Lett. 1999, 40, 8443–8445. (m) Bremner, J. B.; Russell,
H. F.; Skelton, B. W.; White, A. H. Heterocycles 2000, 53, 277–296. (n)
Mascal, M.; Modes, K. V.; Durmus, A. Angew. Chem., Int. Ed. 2011, 50,
4445–4446. (o) Qin, H.; Xu, Z.; Cui, Y.; Jia, Y. Angew. Chem., Int. Ed.
2011, 50, 4447–4449.
Conversion of the C(5000) carbonyl into the spiroimida-
zolone unit with correct relative stereochemistry defined
the next task, Scheme 4. Functionalizing this ketone
proved quite challenging, and curiously, related difficulties
Org. Lett., Vol. 13, No. 20, 2011
5705